Despite the advent of targeted therapies and the associated rise in the use of companion and complementary diagnostics, we are only just emerging from the initial exploratory stages of oncology biomarker testing. As will be argued in this paper, we are on the cusp of a much more radical revolution, and the molecular diagnostics landscape is set to change dramatically in the coming decades. It is crucial that any company entering this space prepare for this imminent upheaval and plan their launch strategy accordingly.
The genesis of a new realm of possibility in manufacturing and supply chain. 3D printing is truly revolutionary. The ability to print bespoke parts and products will transform industrial manufacturing as well as many other sectors including Healthcare.
Advances in science and data let us better support clients in a world that is constantly changing. The Ipsos Science Centre is a world class Data Science team at the intersection of statistics and computer science that allows us to leverage existing and new information in innovative ways to improve the insights and actions of decision makers.